Literature DB >> 14991361

Reversible posterior leucoencephalopathy during oral treatment with methotrexate.

Dimitri Renard, Rene Westhovens, Erik Vandenbussche, Rik Vandenberghe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14991361     DOI： 10.1007/s00415-004-0287-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Clinical reasoning: progressive visuospatial problems in a 71-year-old man.

Authors:  Mkael Symmonds; Wilhelm Küker; Ursula G Schulz
Journal:  Neurology       Date:  2014-07-01       Impact factor: 9.910

2.  Omega-3 offers better hypothalamus protection by decreasing POMC expression and elevating ghrelin hormone: a prospective trial to overcome methotrexate-induced anorexia.

Authors:  Heba Mostafa; Lamia Barakat; Walied S Abdo; Rania M Khalil
Journal:  Endocrine       Date:  2020-05-18       Impact factor: 3.633

Review 3.  Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature.

Authors:  Anmol Dhillon; Celso Velazquez; Chokkalingam Siva
Journal:  Rheumatol Int       Date:  2012-07-24       Impact factor: 2.631

Review 4.  The double-edged sword: Neurotoxicity of chemotherapy.

Authors:  Rajiv S Magge; Lisa M DeAngelis
Journal:  Blood Rev       Date:  2014-09-28       Impact factor: 8.250

5.  Regression of chronic posterior leukoencephalopathy after stop of methotrexate treatment.

Authors:  Gabriella Marcon; Anna Rita Giovagnoli; Paola Mangiapane; Alessandra Erbetta; Fabrizio Tagliavini; Floriano Girotti
Journal:  Neurol Sci       Date:  2009-07-21       Impact factor: 3.307

6.  Leukoencephalopathy due to oral methotrexate.

Authors:  I González-Suárez; M J Aguilar-Amat; M Trigueros; A M Borobia; A Cruz; J Arpa
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.